Halogen-substituted isoindoline compound and use thereof
EP4516785A1Pending Publication Date: 2025-03-05CHENGDU FENDI PHARM CO LTD
-1 Cites 0 Cited by
Patent Information
- Application Number
- EP2023794677
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-04-29
- Filing Date
- 2023-02-02
- Publication Date
- 2025-03-05
Smart Images
Figure IMGA0001_ABST
Abstract
The present invention relates to a halogen-substituted isoindoline compound represented by formula I below and use thereof. The compound of the present invention has significantly better anti-tumor activity, and can be prepared into an oral dosage form which is more convenient, safe, and economical. Therefore, the utilization value of the compound is remarkably improved compared with that of an existing compound.
Need to check novelty before this filing date? Find Prior Art